Newron Pharmaceuticals SpA EBITDA 2024-2023 | NWPHF
Newron Pharmaceuticals SpA ebitda from 2024 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Newron Pharmaceuticals SpA Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-14 |
| 2021 | $-14 |
| 2020 | $-20 |
| 2019 | $-23 |
| 2018 | $-18 |
| Newron Pharmaceuticals SpA Quarterly EBITDA (Millions of US $) |
|---|
